IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.56) per share.
Despite Capital Budget Softness, Long Term Opportunity Remains Intact For Intuitive Surgical: Raymond James Analyst
Yesterday, Intuitive Surgical Inc (NASDAQ:ISRG) reported lower-than-expected Q2 earnings. Raymond James writes, “we were worried about the capital equipment environment, we admittedly…